Report examines what happens when patients stop GLP-1 drugs
Coverage of weight regain and discontinuation patterns after semaglutide and tirzepatide therapy ends.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 2 14:23 ETSource: BusinessWorld Online
The wire
- 01The item relays reporting on outcomes for patients who discontinue GLP-1 weight-loss medication.
- 02Discontinuation and regain drive refill economics and counselling for telehealth and compounding operators.
- 03No new primary data is presented; the piece summarises existing reporting rather than a fresh study.
From the source
Read at bworldonline.comglp-1 weight loss drugs stop what happens wsj article
